Search results
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo Finance· 18 hours agoOn BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the...
What's Going On With Pfizer Stock On Thursday? By Benzinga
Investing.com· 6 days agoWhat's Going On With Pfizer Stock On Thursday?
BioNTech (BNTX) to Release Earnings on Monday
ETF DAILY NEWS· 2 days agoBioNTech (NASDAQ:BNTX – Get Free Report) is scheduled to be posting its quarterly earnings results before the market opens on Monday, May 6th. Analysts expect BioNTech ...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 7 days agoPfizer stock is trading near an 11-year low as the drugmaker looks for its next big break after...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 2 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 days agoThe company is a leader in the neuroscience space. It recently dosed the first patient in a study of...
Wall Street plunges after US inflation shock
The Telegraph via Yahoo Finance· 6 days agoUS stock markets plunged amid fears of stagflation in the American economy, which grew at its slowest pace in nearly two years just as inflation jumped.
CureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 days agoCureVac N.V. (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript April 24, 2024 CureVac N.V. isn’t one of...
CureVac to cut costs in restructuring
BioPharma Dive via Yahoo Finance· 7 days agoThe mRNA vaccine maker, which has lost most of its value since early 2021, is undergoing an “organizational redesign” that will eliminate 150 positions.
Xaira Therapeutics $1 billion funding round shows the excitement about AI drug discovery
Fortune· 6 days agoThe pursuit to use AI to discover new life-saving drugs got a big boost this week when a new company, Xaira Therapeutics, emerged from stealth with $1 billion in funding. The San Francisco-based ...